JPXN:NYE-iShares JPX-Nikkei 400 ETF (USD)

ETF | Japan Stock |

Last Closing

USD 76.81

Change

+0.88 (+1.16)%

Market Cap

N/A

Volume

4.20K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-04 )

Largest Industry Peers for Japan Stock

Symbol Name Price(Change) Market Cap
FLJP Franklin FTSE Japan ETF

+0.31 (+1.03%)

USD 2.18B
DBJP Xtrackers MSCI Japan Hedged Eq..

+1.88 (+2.59%)

USD 0.44B
FLJH Franklin FTSE Japan Hedged ETF

+0.84 (+2.73%)

USD 0.08B
DFJ WisdomTree Japan SmallCap Divi..

+0.73 (+0.92%)

N/A
DXJ WisdomTree Japan Hedged Equity..

+3.10 (+2.88%)

N/A
EWJ iShares MSCI Japan ETF

+0.93 (+1.31%)

N/A
GSJY Goldman Sachs ActiveBeta® Jap..

+0.56 (+1.42%)

N/A
HEWJ iShares Currency Hedged MSCI J..

+1.10 (+2.64%)

N/A
SCJ iShares MSCI Japan Small-Cap E..

+0.44 (+0.56%)

N/A

ETFs Containing JPXN

N/A

Market Performance

  Market Performance vs. Industry/Classification (Japan Stock) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.97% 50% F 64% D
Dividend Return 0.87% 40% F 15% F
Total Return 13.84% 50% F 59% D-
Trailing 12 Months  
Capital Gain 21.48% 70% C- 56% F
Dividend Return 2.97% 70% C- 41% F
Total Return 24.45% 70% C- 54% F
Trailing 5 Years  
Capital Gain 26.08% 50% F 58% F
Dividend Return 6.76% 30% F 20% F
Total Return 32.85% 40% F 52% F
Average Annual (5 Year Horizon)  
Capital Gain 4.99% N/A N/A 55% F
Dividend Return 6.27% N/A N/A 51% F
Total Return 1.29% N/A N/A 30% F
Risk Return Profile  
Volatility (Standard Deviation) 18.20% N/A N/A 56% F
Risk Adjusted Return 34.48% N/A N/A 52% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike